Using Pathomic Features to Differentiate Dysplastic Cells in Myelodysplastic Syndrome
Author Information
Author(s): Hong Youngtaek, Jeong Seri, Park Min-Jeong, Song Wonkeun, Lee Nuri
Primary Institution: Hallym University College of Medicine
Hypothesis
Can pathomic features effectively differentiate between dysplastic and normal hematopoietic cells in patients with myelodysplastic syndrome?
Conclusion
Pathomic features can help distinguish between dysplastic and normal cells in hematologic malignancies, suggesting their potential as a new biomarker for diagnosis.
Supporting Evidence
- Pathomic features were extracted from 12,360 hematopoietic cells.
- The study included 24 patients with myelodysplastic syndrome and 21 normal controls.
- Quadratic discriminant analysis with gradient boosting decision tree achieved an AUROC of 0.63.
- Dysplastic cells showed lower median values in pathomic features compared to normal cells.
- Statistical analysis was performed using the Mann–Whitney test.
Takeaway
This study looks at how special features of cells can help doctors tell the difference between sick and healthy cells in patients with a blood disorder.
Methodology
The study analyzed bone marrow samples from 24 patients with myelodysplastic syndrome and 21 normal controls, extracting 476 pathomic features from 12,360 hematopoietic cells.
Potential Biases
Potential bias in labeling due to subjective interpretation by pathologists.
Limitations
The small sample size limits the generalizability of the findings and the study lacks external validation.
Participant Demographics
Median age of MDS patients was 70.5 years, with 14 males and 10 females; normal group had a median age of 64.0 years, with 12 males and 9 females.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website